Sesen Bio, Inc. (SESN) Stock: Why It’s Gaining In Value


Sesen Bio, Inc. (SESN) is headed up in the market today. The stock, focused in the biotechnology industry, is currently trading at $1.13 after a move up of 5.12% so far today. When it comes to biotech stocks, there are several factors that have the ability to generate price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines associated with SESN:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-27-19 07:29AM The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO
Aug-26-19 04:05PM Sesen Bio Announces CFO Transition as Company Drives Towards Anticipated Initiation of BLA Submission in 4Q 2019
Aug-08-19 04:01PM Sesen Bio Reports Positive, Preliminary Data Update from Phase 3 VISTA Trial for High-Risk Non-Muscle Invasive Bladder Cancer
Aug-05-19 07:30AM Sesen Bio Strengthens Leadership Team
Jul-31-19 07:30AM Sesen Bio to Present at the Canaccord Genuity 39th Annual Growth Conference

Nonetheless, when making an investing decision, prospective investors should look into much more than news, this is especially the case in the speculative biotechnology sector. Here’s what’s happening in regard to Sesen Bio, Inc..

Recent Trends From SESN

While a move toward the top in a single session, like what we’re seeing from Sesen Bio, Inc. might lead to excitement in some investors, a single session move by itself should not be the basis of a decision to, or not to, invest in a company. It’s generally a good idea to dig into trends experienced by the stock beyond a single session. As it relates to SESN, here are the movements that investors have experienced:

  • Past 5 Trading Sessions – Over the past 5 trading sessions, SESN has generated a price change that amounts to 1.35%.
  • Past Month – The ROI from Sesen Bio, Inc. throughout the last 30 days has been 1.80%.
  • Past 3 Months – Over the past 3 months, the stock has generated a return on investment that comes to -33.53%
  • Bi-Annually – Over the past six months, we have seen a change that amounts to 17.05% from the stock.
  • Year To Date – Since the close of last year SESN has resulted in a return on investment of -20.42%.
  • Annually – Finally, over the last full year, we have seen performance amounting to -49.10% out of SESN. Throughout this period, the stock has traded at a high price of -56.54% and a low price of 70.98%.

Key Ratios

Digging into various key ratios having to do with a company can give investors a look of how dangerous and/or potentially profitable a stock pick might be. Below are a few of the key ratios to consider when digging into SESN.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is headed for declines. Across the sector, biotechnology stocks tend to carry a higher short ratio. On the other hand, we tend to see a lot of short squeezes in the space. Nonetheless, when it comes to Sesen Bio, Inc., it’s short ratio amounts to 2.39.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Essentially, they measure whether or not a company can pay its debts as they mature with only current assets or quick assets. Because many biotech companies rely heavily on continued investor support, the quick and current ratios can be damning. Nonetheless, quite a few better companies in the biotechnology sector do have strong quick and current ratios. As far as SESN, the quick and current ratios come to 8.50 and 8.50 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the current book value of assets owned by the company. In this case, that ratio works out to 0.19.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the value of shares. Many early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech space, this is a very important ratio to look into. In terms of SESN, the cash to share value comes to 0.67.

Analyst Opinions Of Sesen Bio, Inc.

Although it’s rarely a good idea to unknowingly follow the thoughts of analysts, it is a good idea to consider their analysis when validating your own thoughts before making an investment decision in the biotech space. Below are the most recent moves that we have seen from analysts as it relates to SESN.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-11-19 Upgrade H.C. Wainwright Neutral → Buy $3

What Institutions And Insiders Think Of Sesen Bio, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in SESN, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors hold 31.70% of Sesen Bio, Inc.. Nonetheless, it’s worth noting that institutional ownership has moved in the amount of 51.13% in the past quarter.
  • Insiders – When it comes to insiders, those close to the company currently hold 6.56% of Sesen Bio, Inc.. Their ownership of the company has changed in the amount of 0 throughout the last quarter.

What You Need To Know About Share Counts

Traders and investors seem to have an interest in the counts of shares both outstanding and available. As it relates to Sesen Bio, Inc., there are currently 96.37M with a float of 96.37M. These numbers mean that out of the total of 96.37M shares of SESN currently in existence today, 96.37M are able to be traded on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to SESN, the short percent of the float is 4.54%.

Financial Performance

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.54. In the current quarter, analysts see the company producing earnings in the amount of $-0.12. Over the last 5 years, SESN has generated revenue in the amount of $0 with earnings coming in at 49.20%. On a quarter over quarter basis, earnings have seen movement of -323.90% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play an important part in my ability to learn. Sure, I can comb through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have a teacher. If you’d like to teach me something, I would love to learn! Is there other information that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here